Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-25 @ 1:38 AM
NCT ID:
NCT04161794
Eligibility Criteria:
Inclusion Criteria:
* histopathologically or cytologically verified with NSCLC
* inoperable tumour, candidates for, but naïve to or no systemic anti-neoplastic treatment the previous two years
* commence first line of chemotherapy (carboplatin/vinorelbin, cisplatin/vinorelbin) with or without radiation therapy or pembrolizumab
* performance status ≤2 (Eastern Cooperative Oncology Group)
* age \>18 and provided oral
* written consent
Exclusion Criteria:
* excessive alcohol or drug abuse
* incapable to follow the intervention (i.e. cognitive problems or unable to walk) were excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04161794
Study Brief:
Protocol Section:
NCT04161794